The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma

Chemotherapy resistance is still a major problem in the treatment of patients with non-small-cell-lung carcinoma (NSCLC), and novel concepts for the induction of cytotoxicity in NSCLC are highly warranted. Proteotoxicity, the induction of cytotoxicity by targeting the ubiquitin proteasome system, re...

Descripción completa

Detalles Bibliográficos
Autores principales: Besse, Lenka, Kraus, Marianne, Besse, Andrej, Driessen, Christoph, Tarantino, Ignazio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023769/
https://www.ncbi.nlm.nih.gov/pubmed/36932175
http://dx.doi.org/10.1038/s41598-023-31400-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023769/
https://www.ncbi.nlm.nih.gov/pubmed/36932175
http://dx.doi.org/10.1038/s41598-023-31400-6

Ejemplares similares